Venture Life Group (LON:VLG) Insider Purchases £60,087.68 in Stock

Venture Life Group plc (LON:VLG) insider Paul McGreevy purchased 93,887 shares of the stock in a transaction on Tuesday, June 30th. The stock was acquired at an average cost of GBX 64 per share, with a total value of £60,087.68.

Paul McGreevy also recently made the following trade(s):

• On Wednesday, June 3rd, Paul McGreevy acquired 15,663 shares of Venture Life Group stock. The shares were purchased at an average price of GBX 64 per share, with a total value of £10,024.32.
• On Wednesday, June 3rd, Paul McGreevy purchased 48,373 shares of Venture Life Group stock. The shares were purchased at an average price of GBX 62 per share, for a total transaction of £29,991.26.
• On Wednesday, June 3rd, Paul McGreevy purchased 8,066 shares of Venture Life Group stock. The shares were purchased at an average cost of GBX 62 per share, with a total value of £5,000.92.
• On Wednesday, June 3rd, Paul McGreevy acquired 8,105 shares of Venture Life Group stock. The stock was acquired at an average cost of GBX 62 per share, for a total transaction of £5,025.10.

Venture Life Group Stock Up 0.8%

VLG traded up GBX 0.50 during trading on Tuesday, hitting GBX 67. 509,774 shares of the company’s stock traded hands, compared to its average volume of 303,704. The company’s 50 day simple moving average is GBX 61.27 and its two-hundred day simple moving average is GBX 64.91. The company has a current ratio of 4.71, a quick ratio of 1.48 and a debt-to-equity ratio of 0.82. Venture Life Group plc has a 12-month low of GBX 52 and a 12-month high of GBX 72. The stock has a market capitalization of £81.62 million, a price-to-earnings ratio of 15.33, a PEG ratio of 5.67 and a beta of 0.23.

Venture Life Group (LON:VLG) last posted its quarterly earnings results on Tuesday, March 31st. The company reported GBX (1.49) earnings per share for the quarter. Venture Life Group had a return on equity of 7.82% and a net margin of 17.42%.The business had revenue of GBX 3,517 million during the quarter. Analysts predict that Venture Life Group plc will post 6.1391542 earnings per share for the current fiscal year.

Venture Life Group Company Profile

Venture Life is an international consumer self-care company focused on developing and commercialising products for the global self-care market helping our consumers live a longer healthier and more rewarding life.

Headquartered in the UK, the Group’s product portfolio includes Balance Activ in the area of women’s intimate healthcare, Earol® supporting ENT care, Lift and Glucogel product ranges for energy and glucose management and hypoglycaemia, plus the Health & Her product range supporting the hormonal lifecycle.

The products, which are typically recommended by pharmacists or healthcare practitioners, are available primarily through health & beauty stores, pharmacies, grocery multiples and e-commerce channels and are sold globally.